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Prevention ofenvironmentally related cancer will be enhanced bythe availability ofsensitive earlywarning
systems and by improvements in quantitative assessment ofhuman risks. Accordingly, we have carried out a
series of molecular epidemiologic studies aimed at validating a panel of biologic markers, including
carcinogen-DNA and -protein adducts, sister chromatid exchange, micronucleus formation, DNA strand
breaks,andDNArepaircapacity. Results fromthreesuch studies illustratethe usefulnessofthesebiomarkers
inelucidatinglow-dose-response relationships, correlations betweenbiomarkers, andtherangeofvariation in
biomarkers between individuals exposed to similar concentrations of carcinogens. Low-level workplace or
ambient exposures to styrene, ethylene oxide, and polycyclic aromatic hydrocarbons (PAH) were associated
with significant increases in both moleculardose ofcarcinogens (adducts) andvarious markers ofpreclinical
effects. Correlations between biomarkers varied by exposure. For example, in the styrene study, sister
chromatid exchange frequency was not correlated with any of the markers, in contrast to the studies of
ethyleneoxideandPAH.Significant moleculareffects wereobservednotonlyinoccupationallyexposedpeople
but also in residents ofan area in Poland characterized by high levels ofair pollution. For example, the mean
PAH-DNA level in exposed residents (winter sample) was 30.4 adducts per 108 nucleotides. This level was
significantly higher than that ofadducts seen in summer samples from the same area (4.2/101), or in winter
samples from residents of a rural area (11.01/108). Significant seasonal variation in PAH-DNA adduct
formation in this group was consistent with recorded fluctuations in air pollution levels. Striking interin-
dividual variation was observed in all three exposed populations.
Introduction
Recent studies of"model" human exposures to environ-
mental carcinogens have demonstrated the value of bio-
logic markers in elucidating low-dose-response relation-
ships, correlations between molecular dose and molecular
effects of carcinogens, and the extent of interindividual
variation in molecular response to carcinogens. These
threepiecesofinformation areofgreatvalueinestimating
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the magnitude ofhuman risk resulting from environmen-
tal exposures.
Recent Research on Styrene
The first investigation we discuss concerns workplace
exposure to styrene (1). Styreneisusedincreasinglyinthe
production ofplastics, resins, and synthetic rubbers. The
most extensive exposures occur through inhalation at
workplaces where fiberglass-reinforced plastic products,
such as boat hulls and bath enclosures, are manufactured.
CurrentU.S. OccupationalSafetyand HealthAdministra-
tion regulations were recently lowered from apermissible
8-hr time-weighted average (TWA) exposure of 100 to 50
ppm.
Styreneanditsprincipalmetabolite, styreneoxide,have
been shown to be mutagenic and toxic to animals and
humans. Binding of styrene to proteins, especially thePERERA ET AL.
N-terminal valine ofhemoglobin (Hb), has been measured
in both animals and humans (2,3). Both styrene and its
oxide are animal carcinogens, and there is preliminary
evidence associating occupational exposure to styrene
with increased incidences of lymphomas and leukemias
(4,5).
In our study ofexposedworkers and controls, exposure
assessmentincludedpersonalmonitoringto measure aver-
age ambient exposure to styrene in air (TWA-ppm) and
analysis ofend-of-shift urine samples to determine levels
of mandelic acid, the principal styrene metabolite. The
panel of biomarkers included a chemical-specific marker
(styrene-Hb adducts) that could serve as a surrogate for
styrene-DNA binding as well as several nonspecific
markers: sister chromatid exchange (SCE), micronucleus
formation (MN), and single-strand breaks (SSB). The
panel was chosen to reflect the internal dose of styrene
mandelic acid, its biologically effective dose (styrene-Hb
adducts), and certain biologic effects of exposure (SCE,
MN, SSB). A measure of susceptibility to DNA damage
[N-acetoxy-2-acetylaminofluorene (NA-AAF) binding]
was alsoincluded. To ourknowledge, thisisthefirst useof
gas chromatography-mass spectrometry to measure
styrene-Hb adducts in humans. Although all ofthe other
assays used in this study had previously been employed
with positive results in at least one other study involving
human populations exposed to ambient styrene, no prior
study had evaluated all of these markers in the same
cohort. [See Brenner et al. (1) for additional background
and references.]
The14malestyrene-exposedfiberglass-reinforced plas-
ticsworkers wereemployed at aNewEnglandplantwhere
small motor and sailboat hulls were manufactured. Con-
trols were five male and four female library workers at a
university in New York State. At both work sites, a phle-
botomist drew 45-mL blood samples using heparinized
Vacutainertubes. Allsamples were drawn atthe sametime
of day (early afternoon) during 2 consecutive days and
coded to assure confidentiality. Coded samples were
assayed for the five biomarkers as described (1).
At the time of blood sample collection, all participants
were interviewed to determine age, educational attain-
ment as a measure of socioeconomic status, total number
of years worked in current occupation, length of time at
current job site, typical or most common job performed
duringthe4 months precedingthe study, use ofprotective
clothing orequipment, and otherenvironmental exposures
and health-related variables that could influence the levels
ofbiomarkers studied.
Breathing zone concentrations ofambient styrene were
measured by personal sampling with 3M Organic Vapor
Monitor #3520 (passive diffusion badges). Urine samples
were collected atthe end ofthework shiftfrom a subset of
theworkers and analyzedformandelic acid and creatinine.
Additional personal air samples were collected from this
same subset using charcoal tubes.
With the exception ofthe method for analysis ofSCE in
high-frequency cells (SCEHFC), in which the chi-square
test was used, the nonparametric Wilcoxon rank-sum test
was used to compare differences in geometric mean levels
ofbiomarkers found amongexposedworkers and controls.
Analysesofvarianceandcovariancewereappliedtodeter-
mine relationships between the dependent and indepen-
dent variables.
Personal monitoring data showed that the fiberglass-
reinforced plastics workers were exposed to a geometric
mean TWA level of 11.2 ppm (±+ 0.9) styrene, with indi-
vidualTWAexposuresrangingfrom 1 to44ppm.Thiswas
equivalent to an arithmetic mean of 17.2 (+ 15.2) ppm.
Estimated styrene exposure, extrapolated from mandelic
acid levels, averaged 15.2 ppm (±+ 0.9) (243.5 mgmandelic
acid/g creatinine) and ranged from 6 to 156 ppm.
The results oflaboratory assays are shown in Tables 1
and 2. Even at the relatively low exposure levels encoun-
tered in this study, four of the five biomarkers showed
elevated levels in styrene-exposed workers compared to
controls (styrene-Hb adducts, MN, SSB, and NA-AAF
binding). For three of these (MN, SSB, and NA-AAF
binding), the mean differences were significant; therewas




tinuous measurements of current or cumulative exposure
wereused (TWA-ppm,mandelic acidinurine, orppm-years).
When, however, we used the trichotomized variable,
"exposure category," derived from an individual's "usualjob
assignment" during the 4 months preceding the study, we
saw dose-response relationships with three of the bio-
markers: styrene-Hb adducts, MN, and NA-AAF binding.
There was significant interindividual variation in levels
ofstyrene-Hbadductsamongexposedworkers. Forexam-
ple, the marked increase in mean adduct level among the
exposed workers was due largely to a reproducibly high
level measured in one worker who was a laminator in the
high-exposure category. Thisindividualalsohadthehigh-
estlevels ofurinarymandelic acidfoundin the study. This
finding ofan extremely elevated styrene-Hb value in one
highly exposed individual may reflect an interaction
between exposure to styrene and biologic sensitivity. The
range of adduct values for workers was on the order of
8-fold (excluding the individual with the highest reading)
or > 5000-fold(includingthisindividual).ThelevelsofMN,
SSB, and NA-AAF bindingvaried by approximately 2- to
3-fold.
Table 1. Styrene-hemoglobin adductsa in blood samples
from fiberglass-reinforced plastics workers and controls.
Geometric
Subjects mean ± SE Range n
All exposed 9.5 ± 2.2 2.0-11,159 14
5.5 ± 0.4 2.0-15.3 13b
Highexposure 34.5 ± 11.6 5.3-11,159 5
8.1 ± 0.8 5.3-15.3 4b
Medium/lowexposure 4.7 ± 0.7 2.0-14.6 9
Controls 2.2 ± 6.8 0.002-24 8
aRatio ofN'-(1-hydroxy-2-phenylethyl) valine to D4-(hydroxyethyl)-
valine standard.
bExcluding one individual with a high level ofadducts.
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ITable 2. Presence ofother biomarkers in blood samples from fiberglass-reinforced plastics workers and controls: geometric means + SE.
Sister chromatid exchange Micronucleus formation Single-strand breaks 3H-NA-AAF binding
Subjects Mean no./cell Range n Mean no./cell Range n -log F(DS) Range n cpm/p.g DNA Range n
All exposed 9.7 ± 0.4 8.2-11.4 10 10.3 0 O.4a 8-14 10 0.25 0.02b 0.10-0.34 14 373.9 + 0.4c 287-479 11
High
exposure 10.0 ± 0.6 8.7-11.0 4 10.8 ± 0.6 9-11 4 0.22 ± 0.01 0.17-0.25 5 369.0 ± 0.7 317-383 3
Medium/low
exposure 9.4 ± 0.5 8.2-11.0 6 10.0 ± 0.5 8-14 6 0.27 ± 0.02 0.10-0.34 9 375.8 ± 0.4 287-479 8
Controls 10.1 ± 0.4 7.8-12.3 9 6.5 ± 0.5 4-13 9 0.15 ± 0.01 0.12-0.20 8 159.5 ± 0.7 99-232 9
aExposed workers versus controls; Wilcoxon rank sum, p < 0.004.
bExposedversus controls; p < 0.003.
cExposed versus controls; p < 0.0002.
Significant correlations were seen between styrene-Hb sity library (6). Comprehensive environmental histories
adductlevels andMN,betweenMNandSSB, andbetween were obtained for each subject, including detailed occupa-
NA-AAF binding and MN (p < 0.05). NA-AAF binding tional and smoking histories. Industrial hygiene data
was also correlated with SSB (p < 0.05). obtained prior to the study and personal monitoring dur-
ing the 8 years preceding the study showed that workers
Recent Research on Ethylene Oxide were subject to low-level exposure near or below the
current Occupational Safety and Health Administration
Ethylene oxide (EtO)is analkylatingagent and amodel standard of1 ppm (TWA).
directlyactingmutagenandcarcinogen. In arecentstudy, Coded blood samples were analyzed as described pre-
we evaluated a panel ofbiologic markers including EtO- viously (6). The results are shown in Table 3.After adjust-
Hb adducts, SCE, MN, chromosomal aberrations, SSBs, ing for smoking, EtO exposure was significantly (p <
and anindexofDNArepair(theratio ofunscheduled DNA 0.001) associated with EtO-Hb adduct levels and two
synthesis to NA-AAF DNA binding) in the peripheral measures of SCE [the average number of SCEs/cell
blood cells of 34 workers at a sterilization unit of a large (SCE50) and SCEHFC]; a marked interaction was seen
university hospital and 23 controls working in the univer- between smoking and workplace exposure for both meas-
Table 3. Biologic markers in ethylene oxide-exposed workers and controls stratified by smoking status: means ± SE.
Workers Controls Two-way ANOVAa
Nonsmokers Smokers Nonsmokers Smokers Smoking Exp. Interaction
Biomarkers (n) (n) (n) (n) p p p
EtO-Hbb 138.79 ± 12.21 234.34 + 39.56 45.30 ± 3.12 149.74 ± 38.52 0.000* 0.000 0.019*
(19) ( 9) (16) ( 4)
SCEHFCe 1.67 ± 0.51 6.17 ± 1.18 1.00 ± 0.52 2.00 ± 0.71 0.001 0.003 0.070
(18) (12) ( 6) (16)
SCEHFCb 1.75 ± 0.46 6.90 ± 1.30 1.22 ± 0.38 4.00 ± 2.35 0.000 0.178 0.516
(20) (10) (18) ( 4)
SCE50c 10.17 ± 0.33 12.51 ± 0.71 9.49 ± 0.60 10.31 ± 0.39 0.002* 0.006* 0.218
(19) (10) ( 6) (16)
SCE50b 10.22 ± 0.31 12.96 ± 0.81 9.75 ± 0.33 11.61 ± 0.71 0.000* 0.164 0.605
(21) ( 8) (18) ( 4)
Micronucleic 12.53 ± 1.44 15.25 ± 1.72 13.50 ± 1.93 14.65 ± 1.09 0.177 0.655 0.593
(19) (12) ( 6) (17)
Micronuclei- 12.62 ± 1.34 15.60 ± 1.96 13.90 ± 1.02 16.50 ± 2.26 0.107 0.215 0.915
(21) (10) (19) ( 4)
CAC 2.65 ± 0.44 2.08 ± 0.51 4.17 ± 0.83 2.07 ± 0.51 0.081 0.993 0.382
(20) (12) ( 6) (15)
CAb 2.48 ± 0.40 2.33 ± 0.65 2.89 ± 0.54 1.33 ± 0.33 0.134 0.451 0.157
(23) ( 9) (18) ( 3)
SSBC 0.17 ± 0.02 0.13 ± 0.01 0.13 ± 0.01 0.14 + 0.01 0.232 0.782 0.125
(19) (13) ( 6) (17)
SSBb 0.17 ± 0.02 0.12 ± 0.01 0.15 ± 0.01 0.10 ± 0.01 0.030* 0.263 0.938
(21) (11) (19) ( 4)
Repair indexc 2.11 ± 0.15 2.17 ± 0.20 2.38 ± 0.24 2.52 ± 0.23 0.749 0.125 0.956
(19) (13) ( 6) (15) b Repair index 2.12 ± 0.15 2.17 ± 0.21 2.35 ± 0.15 3.03 ± 0.67 0.389 0.066 0.404
(21) (11) (17) ( 4)
Abbreviations: EtO, ethylene oxide; Hb, hemoglobin; SCE, sister chromatid exchange; HFC, high frequency cells; CA, chromosomal aberrations;
SSB, single-strand breaks.
1Iwo-way analysis ofvariance, based on ln-transformed data.
bSmokers include current smokers only; nonsmokers include former smokers.
cSmokers include current and former smokers.
-p < 0.05.
135PERERA ET AL.
ures ofSCE (p < 0.004). There was an apparent suppres-
sion ofDNArepaircapacityinEtO-exposedindividuals as
measured bythe DNArepair index (p < 0.01); no associa-
tion was found between DNA repair index and smoking.
EtO-Hb adduct levels were highly correlated with the
frequency ofSCEHFC (p < 0.01) and SCE (p < 0.02); this
observation provides evidence of a direct link between a
marker ofbiologically effective dose and markers of gen-
otoxic response. In contrast, the frequencies ofMN, chro-
mosomal aberrations, and SSB were not significantly
elevated in the workers.
Previous studies of small numbers of sterilization
workers showed increases in Hb alkylation (7,8), in con-
trast to the results ofan investigation byVan Sittert et al.
(9), involvingworkers with verylow-level exposure (gener-
ally < 0.05 ppm) in an EtO manufacturing plant (32
workers, 31controls). In noneofthesestudies wassmoking
adequatelyevaluated. Thepresentfindings arethefirst,to
our knowledge, to show elevated EtO-Hb binding in a
workplace with atmospheric concentrations near or below
1 TWA ppm, in which the effect ofcigarette smoking was
adequately taken into account. Although a body oflitera-
ture demonstrates increased cytogenetic damage in EtO-
exposed workers, to our knowledge the present study is
the first to evaluate exposures generally at orbelow1 ppm
(TWA)while accounting appropriately forcigarette smok-
ing.
In this EtO-exposed cohort, there was considerably
greater uniformity of exposure than among boatbuilders
exposed to styrene. Nonetheless, interindividual variation
between workers was significant for EtO-Hb adducts
(> 800-fold), SCE50, SCEHFC, MN, chromosomal aberra-
tions, SSB, and repair index (2- to 13-fold).
Recent Studies of Environmental
Pollution in Poland
In order to evaluate the biologic dose and effects of
ambient pollution, we used an enzyme-linked immunosor-
bent assay (ELISA) to analyze peripheral white blood
cells from Polish residents for the presence of polycyclic
aromatic hydrocarbons (PAH) covalently bound to DNA.
These results were then compared to several other mea-
surements in the same blood samples: carcinogen-DNA
adducts using the 32P-postlabeling method (10) and SCE
(G. Motykiewicz et al., in preparation). This study builds
uponearlierresearchinthe sameindustrial areaofPoland
that showed that residents of industrialized towns had
adduct levels and patterns similar to those of coke-oven
workers, but two to three times higher than those of
residents in a relatively clean rural area (11).
Silesia is a heavily industrialized region of Poland dis-
tinguished by high ambient concentrations of airborne
PAH and other pollutants. The major sources ofPAH are
cokeries, coal-fired poNver plants, and domestic coal- and
wood-burning stoves. Extracts of airborne particulate
matter from this region are remarkably mutagenic and
clastogenic in experimental systems (12).
Peripheral blood samples were collected from residents
living near a large cokerie in Gliwice, but who were not
employed in PAH-generating industries. Estimated
benzo[a]pyrene levels in ambient air in this area range
from 0.057 jig/m3 (January) to 0.015 ug/im3 (May). Con-
trols were drawn from a relatively "clean" rural area of
eastern Poland.
Blood samples were collected in winter and summer
months, as shown in Table 4. The mean PAH-DNAadduct
level measured by ELISAin samples collected from Gliw-
ice residents in the winter exceeded the corresponding
winter samples from the rural control groupby afactorof
about2.8 (p = 0.02). FortheGliwiceresidents,thelevelsin
the winter sample were approximately seven times higher
than in those collected in the summer (p = 0.001). For the
rural controls, thelevel inthewintersampleexceededthat
in the summer sample by a factor of3.5 (p = 0.02). There
was aclearincreaseinPAH-DNAadductlevels acrossthe
four groups (Gliwice residents, winter; rural controls,
winter; Gliwice residents, summer; rural controls, sum-
mer), providing evidence of a dose-response relationship.
These results confirm and extend our earlier finding that
environmental pollution contributes significantly to the
level of PAH-DNA binding (11). Here, a clear seasonal
effect was observed, consistentwith the increase in pollu-
tion duringthewintermonths from combustion ofcoal for
domestic heating.
A seasonal effect was also seen in the level of DNA
adducts measured by 32P-postlabeling (10). This observa-
tion is consistentwith that of a prior study, which showed
that the mutagenicity of ambient air samples from this
region varied markedly by season (13).
Of the three biomarkers measured in a subset of sub-
jects, SCE and adducts by 32P-postlabeling were signifi-
cantly correlated; however, adducts by ELISA were not
correlated with either adducts by postlabeling or SCE.
This finding may be explained, in part at least, by the
relatively small sample size of the subgroup for all three
measures.
All biomarkers showed large interindividual variation
amongthe environmentallyexposed residents: about20-fold
for adducts by 32P-postlabeling and about 2-fold for SCE
frequency (10). For PAH-DNA adducts, the interindividual
variation in the same group was approximately 70-fold.
Table 4. Polycyclic aromatic hydrocarbon-DNA adduct levels in Gliwice residents and rural controls.
Population Sampling period Number Adducts/108a SD
Gliwice residents January-March 20 30.4 31.70
Rural controls March 21 11.01 22.6
Gliwice residents September-October 21 4.20 13.50
Rural controls October 23 3.0 3.30
aAMithmetic means.
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Conclusion
These studies illustrate the advantage ofusing a panel
of biomarkers that reflect the molecular dose of specific
chemicals/agents and irreversible molecular alterations; it
is a more effective means of establishing causality than
conventional monitoring and questionnaires. These stud-
ies also demonstrate the high sensitivity of DNA and
protein adducts, SCE, MN, SSB, and measures ofsuscep-
tibility and DNA repair to various low-level carcinogenic
exposures-both in the workplace and in the ambient
environment.
Results in terms of dose-response relationships and
correlations between biomarkers varywith exposure. For
example, in the styrene study, styrene-Hb adducts, MN,
andNA-AAF bindingshowedsignificant associationswith
exposure; SCE frequency did not. Styrene-Hb adducts,
SSB, andNA-AAFbindingwereeachcorrelatedwithMN,
whereas SCE frequencywasnotcorrelatedwith anyofthe
othermarkers. Inthe EtO study, however, SCE frequency
was responsive to exposure, as was EtO-Hb: these
markers were highly correlated. In contrast, neither MN,
chromosomal aberrations or SSB was elevated in the EtO
workers.
In the case of ambient PAH, the two measures of
adducts (ELISA and 32P-postlabeling) and SCE all dem-
onstrated significant associations with exposure, and all
three showed seasonalvariation. Ofthe three, PAH-DNA
adduct levels by ELISA showed the clearest dose-
responserelationshipbutwasnotcorrelatedwiththeother
two markers. This review leads to the conclusion that the
optimal batteries ofbiomarkers varyby exposure (chemi-
cal composition andpattern), and more research is needed
to fully characterize the relationships between the differ-
ent biomarkers.
Finally, this work indicates that biomarkers can be
useful in accurately characterizing a population at risk in
terms ofvariationinsensitivitytocarcinogenic exposures.
The observed variation in macromolecular binding
between individuals with comparable environmental
exposure to carcinogens is consistentwith data oninterin-
dividual differences in carcinogen activation, detoxifica-
tion, and DNArepair (14,15). Although notwell character-
ized, variations in cellular processes (such as cell replica-
tion rates, age, diet, and immune status) related to promo-
tion ofcarcinogenesis are alsolikelytobe significant. This
is important because the failure ofcurrent procedures for
carcinogenic risk assessment to account explicitly for
humaninterindividualvariationmayresultin asignificant
understatement of the carcinogenic risks of low doses,
especially for the most sensitive individuals, but also for
the population as awhole (16).
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